Business Context and Reporting Period
Company: eXoZymes Inc. (Nasdaq: EXOZ)
Filing Type: Form 8-K (Current Report)
Date of Report: June 5, 2026
Event: Entry into a Material Definitive Agreement for an underwritten public offering of common stock and warrants.
Key Financial Metrics and Offering Details
The filing details a firm commitment underwritten offering with the following terms:
- Securities Issued: 592,270 shares of Common Stock and 292,135 Warrants (sold as units of 2 shares + 1 warrant).
- Offering Price: $18.00 per unit.
- Gross Proceeds (Base): Approximately $5,330,430.
- Underwriting Commissions (Base): $373,130.
- Estimated Offering Expenses: $253,000.
- Over-Allotment Option: MDB Capital holds an option to purchase an additional 88,840 shares and 44,420 Warrants. If fully exercised, gross proceeds would increase to $6,129,990 with commissions of $429,099.
- Warrant Exercise Price: $11.24 per share.
- Warrant Expiration: Five-year anniversary of the offering date.
Material Changes and Use of Proceeds
This filing represents a significant capital raise event. The Company plans to utilize net proceeds for:
- Development of opportunities associated with the NCT business and products.
- Research and development of next-in-line products.
- General corporate purposes, working capital, and capital expenditures.
The filing does not provide comparative financial metrics (revenue, profit, cash flow, or debt levels) for the current or prior periods, as this is a transactional report rather than a periodic financial statement.
Guidance, Risks, and Unusual Items
Warrant Reset Provision (Unusual Item): The offering includes a "Warrant Reset" clause. If the Company sells additional equity at a price below $8.99 per share within one year of the offering, the warrant exercise price will reset to $0.001. This reset is contingent on the original purchaser holding the shares for the full one-year period without transfer (with limited exceptions for estate planning or legal transfers).
Redemption Terms: Warrants may be called for redemption after one year if the stock trades at or above $17.98 for 20 of 30 trading days.
Closing Conditions: The offering is expected to close on or about June 9, 2026, subject to customary conditions.
Investor Verification Checklist
- Verify the final closing date and whether the over-allotment option was exercised.
- Confirm the actual net proceeds received after all commissions and expenses.
- Monitor the stock price relative to the $8.99 threshold to assess the risk of the warrant exercise price resetting to $0.001.
- Review the full Underwriting Agreement (Exhibit 10.1) for specific representations and indemnification obligations.
- Check subsequent filings for the allocation of proceeds to specific R&D projects or NCT business developments.